Sally Wade

3.4k total citations · 1 hit paper
43 papers, 2.5k citations indexed

About

Sally Wade is a scholar working on Oncology, Economics and Econometrics and Orthopedics and Sports Medicine. According to data from OpenAlex, Sally Wade has authored 43 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Economics and Econometrics and 8 papers in Orthopedics and Sports Medicine. Recurrent topics in Sally Wade's work include Bone health and osteoporosis research (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Bone health and treatments (6 papers). Sally Wade is often cited by papers focused on Bone health and osteoporosis research (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Bone health and treatments (6 papers). Sally Wade collaborates with scholars based in United States, United Kingdom and Canada. Sally Wade's co-authors include Kevin Knight, Lodovico Balducci, Chiun‐Fang Chiou, Mary S. Anthony, C. D. O’Malley, C. Strader, Lorraine A. Fitzpatrick, Joshua J. Ofman, Alexander Liede and Rohini K. Hernandez and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

Sally Wade

40 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence and outcomes of anemia in cancer: a systematic review of the literature

2004 640 citations Kevin Knight, Sally Wade et al. The American Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally Wade United States	21	624	511	456	410	300	43	2.5k
Rahul Mhaskar United States	23	693 1.1×	401 0.8×	374 0.8×	135 0.3×	108 0.4×	150	2.0k
Brian D. Bradbury United States	29	229 0.4×	383 0.7×	902 2.0×	220 0.5×	250 0.8×	88	3.3k
Matthew Gitlin United States	21	324 0.5×	365 0.7×	230 0.5×	275 0.7×	139 0.5×	79	1.7k
Mark D. Danese United States	29	485 0.8×	578 1.1×	436 1.0×	208 0.5×	252 0.8×	125	4.3k
Domingo Hernández Spain	36	428 0.7×	1.4k 2.8×	153 0.3×	322 0.8×	54 0.2×	221	4.6k
Jingrong Yang United States	23	380 0.6×	276 0.5×	236 0.5×	304 0.7×	105 0.3×	50	2.7k
Helgi Sigvaldason Iceland	32	688 1.1×	599 1.2×	187 0.4×	69 0.2×	78 0.3×	82	3.3k
Ryan D. Kilpatrick United States	24	159 0.3×	690 1.4×	836 1.8×	275 0.7×	147 0.5×	51	4.2k
Jason Wang United States	27	272 0.4×	885 1.7×	79 0.2×	218 0.5×	79 0.3×	75	2.7k
Ted Wun United States	28	392 0.6×	284 0.6×	684 1.5×	26 0.1×	317 1.1×	75	2.9k

Countries citing papers authored by Sally Wade

Since Specialization

Citations

This map shows the geographic impact of Sally Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Wade more than expected).

Fields of papers citing papers by Sally Wade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Wade. The network helps show where Sally Wade may publish in the future.

Co-authorship network of co-authors of Sally Wade

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Wade. A scholar is included among the top collaborators of Sally Wade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Wade. Sally Wade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cutler, Andrew J., et al.. (2024). Healthcare resource utilization and costs associated with first versus subsequent use of cariprazine for bipolar I disorder. Journal of Medical Economics. 27(1). 1472–1484. 1 indexed citations

Hernandez, Rohini K., Sally Wade, Adam Reich, et al.. (2018). Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. 18(1). 44–44. 246 indexed citations

Lau, Arthur, George Ioannidis, Sally Wade, et al.. (2017). Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting. The Journal of Rheumatology. 45(2). 170–176. 19 indexed citations

Harrold, Leslie R., Bradley S. Stolshek, Sabrina Rebello, et al.. (2017). Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry. Clinical Rheumatology. 36(4). 895–901. 40 indexed citations

Liede, Alexander, Katarzyna J. Jerzak, Rohini K. Hernandez, et al.. (2016). The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Research and Treatment. 156(3). 587–595. 51 indexed citations

Balasubramanian, Akhila, Sally Wade, Robert A. Adler, et al.. (2016). Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporosis International. 27(11). 3239–3249. 78 indexed citations

Barrett‐Connor, Elizabeth, Sally Wade, Robert W. Downs, et al.. (2015). Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™. Osteoporosis International. 26(8). 2175–2184. 1 indexed citations

Wade, Sally, C. Strader, Lorraine A. Fitzpatrick, Mary S. Anthony, & C. D. O’Malley. (2014). Estimating prevalence of osteoporosis: examples from industrialized countries. Archives of Osteoporosis. 9(1). 182–182. 291 indexed citations

Hassan, Mariam, et al.. (2013). Hospitalizations among bipolar disorder patients before and after initiating lurasidone in a commercially insured population. Value in Health. 16(3). A68–A68. 1 indexed citations

10.

Wade, Sally, Jeffrey R. Curtis, Jingbo Yu, et al.. (2012). Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. Bone. 50(4). 870–875. 50 indexed citations

11.

Wade, Sally, C. Strader, Lorraine A. Fitzpatrick, & Mary S. Anthony. (2012). Sex- and age-specific incidence of non-traumatic fractures in selected industrialized countries. Archives of Osteoporosis. 7(1-2). 219–227. 29 indexed citations

12.

Wade, Sally, et al.. (2011). Impact of Medication Adherence on Health Care Utilization and Productivity: Self-Reported Data From a Cohort of Postmenopausal Women on Osteoporosis Therapy. Clinical Therapeutics. 33(12). 2006–2015. 9 indexed citations

13.

Tosteson, Anna N.A., Adrian P. Trifa, Sally Wade, Mary S. Anthony, & Robert W. Downs. (2010). Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™. Osteoporosis International. 21(10). 1769–1780. 27 indexed citations

14.

Barrett‐Connor, Elizabeth, Kristine E. Ensrud, Anna N.A. Tosteson, et al.. (2008). Design of the POSSIBLE US™ Study: postmenopausal women’s compliance and persistence with osteoporosis medications. Osteoporosis International. 20(3). 463–472. 15 indexed citations

15.

Nissenson, Allen R., et al.. (2005). Economic Burden of Anemia in an Insured Population. Journal of Managed Care Pharmacy. 11(7). 565–574. 87 indexed citations

16.

Dubinsky, Marla C., Eileen Reyes, Joshua J. Ofman, et al.. (2005). A Cost-Effectiveness Analysis of Alternative Disease Management Strategies in Patients with Crohn's Disease Treated with Azathioprine or 6-Mercaptopurine. The American Journal of Gastroenterology. 100(10). 2239–2247. 128 indexed citations

17.

Borenstein, Jeff, Chiun‐Fang Chiou, Bonnie B. Dean, John B. Wong, & Sally Wade. (2005). Estimating Direct and Indirect Costs of Premenstrual Syndrome. Journal of Occupational and Environmental Medicine. 47(1). 26–33. 86 indexed citations

18.

Knight, Kevin, Sally Wade, & Lodovico Balducci. (2004). Prevalence and outcomes of anemia in cancer: a systematic review of the literature. The American Journal of Medicine. 116(7). 11–26. 640 indexed citations breakdown →

19.

Ofman, Joshua J., Sean D. Sullivan, Peter J. Neumann, et al.. (2003). Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES. Journal of Managed Care Pharmacy. 9(1). 53–61. 283 indexed citations

20.

Wade, Sally, et al.. (2002). Exploring the Methodological Challenges of Investigating Comparison Groups with Different Underlying Characteristics: A Case Study. Journal of Managed Care Pharmacy. 8(5). 353–359. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact